Probenecid and intraocular methicillin

Annals of Ophthalmology
|February 1, 1981
PubMed

Insights

Probenecid did not significantly extend the intraocular longevity of intravitreal methicillin in rabbits. However, methicillin levels remained adequate to inhibit Staphylococcus aureus for about 20 hours.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Microbiology

Background:

  • Intravitreal antibiotics are crucial for treating intraocular infections.
  • Methicillin is effective against penicillinase-producing Staphylococcus aureus.
  • Optimizing the intraocular drug delivery and longevity is essential for sustained therapeutic effect.

Purpose of the Study:

  • To investigate the effect of probenecid on the intraocular longevity of intravitreal methicillin.
  • To determine if probenecid can enhance the therapeutic duration of methicillin in the eye.

Main Methods:

  • Intravenous administration of probenecid to rabbits.
  • Intravitreal injection of methicillin.
  • Measurement of aqueous humor methicillin levels over time.
  • Assessment of methicillin's inhibitory activity against S. aureus.

Main Results:

  • Probenecid administration resulted in an insignificant elevation of methicillin's half-life.
  • Adequate aqueous methicillin concentrations were maintained for approximately 20 hours.
  • The drug demonstrated sustained inhibitory activity against penicillinase-producing S. aureus.

Conclusions:

  • Probenecid is not effective in significantly prolonging the intraocular longevity of intravitreal methicillin.
  • Intravitreal methicillin provides a substantial duration of antibacterial activity against S. aureus in the aqueous humor.

Related Concept Videos

Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...